Ryvyl (RVYL) had the highest return on May 14, 2018 by a US stock, returning 81.8%.

ASSET	DATE	% RETURN
Ryvyl (RVYL)	5/14/2018	81.82%
Boxlight Corp Class A (BOXL)	5/14/2018	72.01%
Integrated Media Technology (IMTE)	5/14/2018	59.38%
Know Labs (KNW)	5/14/2018	26.67%
Clean Energy Technologies, Inc Common Stock (CETY)	5/14/2018	20.01%
Firefly Neuroscience (AIFF)	5/14/2018	20%
Titan Pharmaceuticals (TTNP)	5/14/2018	20%
Arcadia Biosciences (RKDA)	5/14/2018	19.43%
Nixxy (NIXX)	5/14/2018	18.18%
Eterna Therapeutics (ERNA)	5/14/2018	17.38%
Tandem Diabetes Care (TNDM)	5/14/2018	16.58%
TechPrecision Corporation Common stock (TPCS)	5/14/2018	15.84%
Lixte Biotechnology (LIXT)	5/14/2018	15.38%
INVO Bioscience (INVO)	5/14/2018	15%
NAYA Biosciences (NAYA)	5/14/2018	15%
Daxor (DXR)	5/14/2018	14.97%
ProPhase Labs (PRPH)	5/14/2018	14.76%
Lipocine (LPCN)	5/14/2018	14.41%
Neurobo Pharmaceuticals (NRBO)	5/14/2018	14.4%
MetaVia (MTVA)	5/14/2018	14.4%
Curis (CRIS)	5/14/2018	14.17%
Aytu BioScience (AYTU)	5/14/2018	14.14%
Omeros (OMER)	5/14/2018	13.35%
Galectin Therapeutics (GALT)	5/14/2018	13.31%
Rhythm Pharmaceuticals (RYTM)	5/14/2018	13.01%